| Date Filed | Type | Description |
| 10/13/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/11/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/10/2023 |
4
| Mendelson Daniel Newman (Director) has filed a Form 4 on CHAMPIONS ONCOLOGY, INC.|
Txns:
| Bought 1,530 shares
@ $6.48, valued at
$9.9k
|
|
| 10/06/2023 |
4
| Mendelson Daniel Newman (Director) has filed a Form 4 on CHAMPIONS ONCOLOGY, INC.|
Txns:
| Bought 2,000 shares
@ $6.47, valued at
$12.9k
|
|
| 10/04/2023 |
4
| Mendelson Daniel Newman (Director) has filed a Form 4 on CHAMPIONS ONCOLOGY, INC.|
Txns:
| Bought 2,500 shares
@ $6.3, valued at
$15.8k
|
|
| 10/04/2023 |
4
| Mendelson Daniel Newman (Director) has filed a Form 4 on CHAMPIONS ONCOLOGY, INC.|
Txns:
| Bought 5,000 shares
@ $6.4, valued at
$32k
|
|
| 09/27/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/17/2023 |
4
| ACKERMAN JOEL (Director) has filed a Form 4 on CHAMPIONS ONCOLOGY, INC.|
Txns:
| Granted 26,500 options to buy
@ $7, valued at
$185.5k
|
|
| 08/17/2023 |
4
| Breitfeld Philip P. (Director) has filed a Form 4 on CHAMPIONS ONCOLOGY, INC.|
Txns:
| Granted 11,480 options to buy
@ $7, valued at
$80.4k
|
|
| 08/17/2023 |
4
| Mendelson Daniel Newman (Director) has filed a Form 4 on CHAMPIONS ONCOLOGY, INC.|
Txns:
| Granted 19,430 options to buy
@ $7, valued at
$136k
|
|
| 08/17/2023 |
4
| SIDRANSKY DAVID (Director) has filed a Form 4 on CHAMPIONS ONCOLOGY, INC.|
Txns:
| Granted 11,480 options to buy
@ $7, valued at
$80.4k
|
|
| 08/17/2023 |
4
| TOBIN SCOTT R (10% Owner) has filed a Form 4 on CHAMPIONS ONCOLOGY, INC.|
Txns:
| Granted 21,200 options to buy
@ $7, valued at
$148.4k
|
|
| 07/24/2023 |
10-K
| Annual Report for the period ended April 30, 2023 |
| 07/24/2023 |
8-K
| Quarterly results |
| 04/05/2023 |
8-K
| Regulation FD Disclosure, Other Events, Financial Statements and Exhibits Interactive Data |
| 03/21/2023 |
4
| Morris Ronnie (CEO) has filed a Form 4 on CHAMPIONS ONCOLOGY, INC.|
Txns:
| Bought 12,382 shares
@ $4.0356, valued at
$50k
|
|
| 03/16/2023 |
10-Q
| Quarterly Report for the period ended January 31, 2023 |
| 03/15/2023 |
8-K
| Quarterly results |
| 12/13/2022 |
10-Q
| Quarterly Report for the period ended October 31, 2022 |
| 12/13/2022 |
8-K
| Quarterly results |
| 10/20/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/20/2022 |
8-K
| Quarterly results |
| 10/14/2022 |
4
| SIDRANSKY DAVID (Director) has filed a Form 4 on CHAMPIONS ONCOLOGY, INC.|
Txns:
| Paid exercise price by delivering 3,562 shares
@ $7.51, valued at
$26.8k
Exercised 8,333 options to buy
@ $3.21, valued at
$26.7k
|
|
| 10/14/2022 |
4
| Breitfeld Philip P. (Director) has filed a Form 4 on CHAMPIONS ONCOLOGY, INC.|
Txns:
| Paid exercise price by delivering 3,562 shares
@ $7.51, valued at
$26.8k
Exercised 8,333 options to buy
@ $3.21, valued at
$26.7k
|
|
| 10/13/2022 |
4
| TOBIN SCOTT R (Director) has filed a Form 4 on CHAMPIONS ONCOLOGY, INC.|
Txns:
| Exercised 10,000 options
@ $3.21, valued at
$32.1k
|
|
| 09/12/2022 |
10-Q
| Quarterly Report for the period ended July 31, 2022 |
| 09/08/2022 |
8-K
| Quarterly results |
| 08/31/2022 |
DEF 14A
| Form DEF 14A - Other definitive proxy statements: |
| 08/29/2022 |
DEF 14A
| Form DEF 14A - Other definitive proxy statements: |
| 08/29/2022 |
DEFC14A
| Form DEFC14A - Definitive proxy statement, contested solicitations: |
| 07/22/2022 |
10-K
| Annual Report for the period ended April 30, 2022 |
| 07/21/2022 |
8-K
| Quarterly results |
| 03/15/2022 |
10-Q
| Quarterly Report for the period ended January 31, 2022 |
| 03/15/2022 |
8-K
| Quarterly results |
|